Lehrstuhl für Innere Medizin III

Soluble CD83 Triggers Resolution of Arthritis and Sustained Inflammation Control in IDO Dependent Manner (2019) Royzman D, Andrev D, Stich L, Rauh M, Bäuerle T, Ellmann S, Boon L, et al. Journal article EFFECTS OF BASELINE PREDNISONE DOSE ON REMISSION AND DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB IN THE GIACTA TRIAL (2019) Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, et al. Conference contribution Obesity as an Influence Parameter of rheumatoid Arthritis and Osteoarthritis (Arthrosis) in the Mouse Model (2019) Sauermilch HM, Huelser ML, Schreiyaeck C, Luo Y, Bozec A, Schett G, Mueller-Ladner U, Neumann E Conference contribution First Presentation of idiopathic Mast Cell Activation Syndrome (MCAS) in a Young Person: Association with Histamine and Salicylate Intolerance as well as an important Differential Diagnosis in gastroenterological Problem Patients (2019) Raithel M, Rechenauer T, Goetze T, Siebenlist G, Rueckel A, Baenkler HW, Hartmann A, et al. Conference contribution Depression as comorbidity of rheumatoid arthritis Depression als Komorbidität bei rheumatoider Arthritis (2019) Baerwald C, Manger B, Hueber A Journal article, Review article Depression as comorbidity of rheumatoid arthritis (2019) Baerwald C, Manger B, Hueber A Journal article Receptor Tyrosine Kinase Inhibitor Nintedanib as Treatment Option in Bronchiolitis Obliterans after Airway Transplantation (2019) Heim C, Mauer J, Kuckhahn A, Distler J, Spriewald B, Ramsperger-Gleixner M, Weyand M, Ensminger SM Conference contribution Enzymatically oxidized phospholipids assume center stage as essential regulators of innate immunity and cell death (2019) O'Donnell VB, Aldrovandi M, Murphy RC, Krönke G Journal article, Review article What Are the Peripheral Blood Determinants for Increased Osteoclast Formation in the Various Inflammatory Diseases Associated With Bone Loss? (2019) De Vries TJ, El Bakkali I, Kamradt T, Schett G, Jansen IDC, D'Amelio P Journal article, Review article EFFECTS OF BASELINE PREDNISONE DOSE ON REMISSION AND DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB IN A PHASE 3 RANDOMIZED CONTROLLED TRIAL (2019) Stone J, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, et al. Conference contribution